{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:30:42Z","timestamp":1785364242546,"version":"3.55.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,8,12]]},"DOI":"10.7759\/cureus.43362","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T11:11:10Z","timestamp":1691838670000},"source":"Crossref","is-referenced-by-count":6,"title":["An Insight Into the Factors Affecting the Prevalence and Natural History of Hepatitis D"],"prefix":"10.7759","author":[{"given":"Zaigham","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minaam","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/v14020198","article-title":"Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection","volume":"14","author":"Oberhardt V","year":"2022","unstructured":"Oberhardt V, Hofmann M, Thimme R, Neumann-Haefelin C. Adaptive immune responses, immune escape and immune-mediated pathogenesis during HDV infection. Viruses. 2022, 14:198. 10.3390\/v14020198","journal-title":"Viruses"},{"key":"ref2","article-title":"Hepatitis D (DELTA)","volume":"45","author":"Rizzetto M","year":"2022","unstructured":"Rizzetto M. Hepatitis D (DELTA). New Microbiol. 2022, 45:149-154.","journal-title":"New Microbiol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.01.035","article-title":"Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients","volume":"130","author":"Su CW","year":"2006","unstructured":"Su CW, Huang YH, Huo TI, et al.. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients. Gastroenterology. 2006, 130:1625-1635. 10.1053\/j.gastro.2006.01.035","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban S","year":"2021","unstructured":"Urban S, Neumann-Haefelin C, Lampertico P. Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease. Gut. 2021, 70:1782-1794. 10.1136\/gutjnl-2020-323888","journal-title":"Gut"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.04.008","article-title":"The global prevalence of hepatitis D virus infection: systematic review and meta-analysis","volume":"73","author":"Stockdale AJ","year":"2020","unstructured":"Stockdale AJ, Kreuels B, Henrion MY, et al.. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020, 73:523-532. 10.1016\/j.jhep.2020.04.008","journal-title":"J Hepatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao Z","year":"2020","unstructured":"Miao Z, Zhang S, Ou X, et al.. Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection. J Infect Dis. 2020, 221:1677-1687. 10.1093\/infdis\/jiz633","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2018-316601","article-title":"Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis","volume":"68","author":"Chen HY","year":"2019","unstructured":"Chen HY, Shen DT, Ji DZ, et al.. Prevalence and burden of hepatitis D virus infection in the global population: a systematic review and meta-analysis. Gut. 2019, 68:512-521. 10.1136\/gutjnl-2018-316601","journal-title":"Gut"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1323626","article-title":"Epidemiology of hepatitis D","volume":"32","author":"Rizzetto M","year":"2012","unstructured":"Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis. 2012, 32:211-219. 10.1055\/s-0032-1323626","journal-title":"Semin Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.8210","article-title":"Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis","volume":"13","author":"Amini N","year":"2013","unstructured":"Amini N, Alavian SM, Kabir A, Aalaei-Andabili SH, Saiedi Hosseini SY, Rizzetto M. Prevalence of hepatitis d in the eastern mediterranean region: systematic review and meta analysis. Hepat Mon. 2013, 13:e8210. 10.5812\/hepatmon.8210","journal-title":"Hepat Mon"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2005.03857.x","article-title":"Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan","volume":"20","author":"Mumtaz K","year":"2005","unstructured":"Mumtaz K, Hamid SS, Adil S, et al.. Epidemiology and clinical pattern of hepatitis delta virus infection in Pakistan. J Gastroenterol Hepatol. 2005, 20:1503-1507. 10.1111\/j.1440-1746.2005.03857.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref11","article-title":"Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics","volume":"59","author":"Seetlani NK","year":"2009","unstructured":"Seetlani NK, Abbas Z, Raza S, Yakoob J, Jafris W. Prevalence of hepatitis D in HBsAg positive patients visiting liver clinics. J Pak Med Assoc. 2009, 59:434-437.","journal-title":"J Pak Med Assoc"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v13.i18.2604","article-title":"Clinical presentation and genotype of hepatitis delta in Karachi","volume":"13","author":"Moatter T","year":"2007","unstructured":"Moatter T, Abbas Z, Shabir S, Jafri W. Clinical presentation and genotype of hepatitis delta in Karachi. World J Gastroenterol. 2007, 13:2604-2607. 10.3748\/wjg.v13.i18.2604","journal-title":"World J Gastroenterol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2014.05.041","article-title":"Chronic HDV\/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients","volume":"61","author":"Braga WS","year":"2014","unstructured":"Braga WS, de Oliveira CM, de Ara\u00fajo JR, et al.. Chronic HDV\/HBV co-infection: predictors of disease stage---a case series of HDV-3 patients. J Hepatol. 2014, 61:1205-1211. 10.1016\/j.jhep.2014.05.041","journal-title":"J Hepatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2016.03.017","article-title":"Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir","volume":"46","author":"Borzacov LM","year":"2016","unstructured":"Borzacov LM, de Figueiredo Nicolete LD, Souza LF, Dos Santos AO, Vieira DS, Salcedo JM. Treatment of hepatitis delta virus genotype 3 infection with peg-interferon and entecavir. Int J Infect Dis. 2016, 46:82-88. 10.1016\/j.ijid.2016.03.017","journal-title":"Int J Infect Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(17)30819-X","article-title":"Outcome in chronic hepatitis delta: differences between African and non-African patients","volume":"66","author":"Spaan M","year":"2017","unstructured":"Spaan M, Carey I, Wang B, et al.. Outcome in chronic hepatitis delta: differences between African and non-African patients. J Hepatol. 2017, 66:255-256. 10.1016\/S0168-8278(17)30819-X","journal-title":"J Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.03.025","article-title":"Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates","volume":"75","author":"Wang W","year":"2021","unstructured":"Wang W, Lempp FA, Schlund F, et al.. Assembly and infection efficacy of hepatitis B virus surface protein exchanges in 8 hepatitis D virus genotype isolates. J Hepatol. 2021, 75:311-323. 10.1016\/j.jhep.2021.03.025","journal-title":"J Hepatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13010","article-title":"Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus","volume":"26","author":"Miao Z","year":"2019","unstructured":"Miao Z, Zhang S, Ma Z, Hakim MS, Wang W, Peppelenbosch MP, Pan Q. Recombinant identification, molecular classification and proposed reference genomes for hepatitis delta virus. J Viral Hepat. 2019, 26:183-190. 10.1111\/jvh.13010","journal-title":"J Viral Hepat"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2021.01.014","article-title":"The changing context of hepatitis D","volume":"74","author":"Rizzetto M","year":"2021","unstructured":"Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol. 2021, 74:1200-1211. 10.1016\/j.jhep.2021.01.014","journal-title":"J Hepatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1009","article-title":"Hepatitis B virus and delta infection: special considerations in the indigenous and isolated riverside populations in the Amazon region","volume":"16","author":"Cabezas C","year":"2020","unstructured":"Cabezas C, Braga W. Hepatitis B virus and delta infection: special considerations in the indigenous and isolated riverside populations in the Amazon region. Clin Liver Dis (Hoboken). 2020, 16:117-122. 10.1002\/cld.1009","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.24875\/AIDSRev.20000056","article-title":"Hepatitis delta virus epidemiology in the industrialized world","volume":"22","author":"Toy M","year":"2020","unstructured":"Toy M, Ahishali E, Yurdayd\u0131n C. Hepatitis delta virus epidemiology in the industrialized world. AIDS Rev. 2020, 22:203-212. 10.24875\/AIDSRev.20000056","journal-title":"AIDS Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-021-00693-2","article-title":"The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?","volume":"79","author":"Hayashi T","year":"2021","unstructured":"Hayashi T, Takeshita Y, Hutin YJ, et al.. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response?. Arch Public Health. 2021, 79:180. 10.1186\/s13690-021-00693-2","journal-title":"Arch Public Health"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0369-8114(02)00351-6","article-title":"Hepatitis viruses: mother to child transmission [Article in French]","volume":"50","author":"Ranger-Rogez S","year":"2002","unstructured":"Ranger-Rogez S, Alain S, Denis F. Hepatitis viruses: mother to child transmission [Article in French]. Pathol Biol. 2002, 50:568-575. 10.1016\/s0369-8114(02)00351-6","journal-title":"Pathol Biol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13556","article-title":"Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country","volume":"38","author":"Sellier PO","year":"2018","unstructured":"Sellier PO, Maylin S, Brichler S, et al.. Hepatitis B virus-hepatitis D virus mother-to-child co-transmission: a retrospective study in a developed country. Liver Int. 2018, 38:611-618. 10.1111\/liv.13556","journal-title":"Liver Int"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(99)80185-8","article-title":"Intrafamilial transmission of hepatitis delta virus: molecular evidence","volume":"30","author":"Niro GA","year":"1999","unstructured":"Niro GA, Casey JL, Gravinese E, et al.. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999, 30:564-569. 10.1016\/s0168-8278(99)80185-8","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13755","article-title":"Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis","volume":"29","author":"Salpini R","year":"2022","unstructured":"Salpini R, D'Anna S, Piermatteo L, Svicher V. Novel concepts on mechanisms underlying Hepatitis Delta virus persistence and related pathogenesis. J Viral Hepat. 2022, 29:1038-1047. 10.1111\/jvh.13755","journal-title":"J Viral Hepat"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00430-14","article-title":"Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles","volume":"88","author":"Freitas N","year":"2014","unstructured":"Freitas N, Cunha C, Menne S, Gudima SO. Envelope proteins derived from naturally integrated hepatitis B virus DNA support assembly and release of infectious hepatitis delta virus particles. J Virol. 2014, 88:5742-5754. 10.1128\/JVI.00430-14","journal-title":"J Virol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10117-z","article-title":"Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo","volume":"10","author":"Perez-Vargas J","year":"2019","unstructured":"Perez-Vargas J, Amirache F, Boson B, et al.. Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo. Nat Commun. 2019, 10:2098. 10.1038\/s41467-019-10117-z","journal-title":"Nat Commun"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes SA","year":"2011","unstructured":"Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011, 378:73-85. 10.1016\/S0140-6736(10)61931-9","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(82)90156-8","article-title":"Influence of delta infection on severity of hepatitis B","volume":"320","author":"Smedile A","year":"1982","unstructured":"Smedile A, Farci P, Verme G, et al.. Influence of delta infection on severity of hepatitis B. Lancet. 1982, 320:945-947. 10.1016\/s0140-6736(82)90156-8","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.01.052","article-title":"A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma","volume":"136","author":"Romeo R","year":"2009","unstructured":"Romeo R, Del Ninno E, Rumi M, et al.. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma. Gastroenterology. 2009, 136:1629-1638. 10.1053\/j.gastro.2009.01.052","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.01.004","article-title":"Hepatitis D: thirty years after","volume":"50","author":"Rizzetto M","year":"2009","unstructured":"Rizzetto M. Hepatitis D: thirty years after. J Hepatol. 2009, 50:1043-1050. 10.1016\/j.jhep.2009.01.004","journal-title":"J Hepatol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1136\/gut.46.3.420","article-title":"Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B","volume":"46","author":"Fattovich G","year":"2000","unstructured":"Fattovich G, Giustina G, Christensen E, Pantalena M, Zagni I, Realdi G, Schalm SW. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut. 2000, 46:420-426. 10.1136\/gut.46.3.420","journal-title":"Gut"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-1168-9","article-title":"High rates of cirrhosis and severe clinical events in patients with HBV\/HDV co-infection: longitudinal analysis of a German cohort","volume":"20","author":"Bockmann JH","year":"2020","unstructured":"Bockmann JH, Grube M, Hamed V, et al.. High rates of cirrhosis and severe clinical events in patients with HBV\/HDV co-infection: longitudinal analysis of a German cohort. BMC Gastroenterol. 2020, 20:24. 10.1186\/s12876-020-1168-9","journal-title":"BMC Gastroenterol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.3390\/v13050830","article-title":"Hepatitis D virus and hepatocellular carcinoma","volume":"13","author":"Farci P","year":"2021","unstructured":"Farci P, Niro GA, Zamboni F, Diaz G. Hepatitis D virus and hepatocellular carcinoma. Viruses. 2021, 13:830. 10.3390\/v13050830","journal-title":"Viruses"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1159\/000282076","article-title":"Hepatitis delta: immunopathogenesis and clinical challenges","volume":"28","author":"Grabowski J","year":"2010","unstructured":"Grabowski J, Wedemeyer H. Hepatitis delta: immunopathogenesis and clinical challenges. Dig Dis. 2010, 28:133-138. 10.1159\/000282076","journal-title":"Dig Dis"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31214","article-title":"Long-term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver-related outcomes","volume":"72","author":"Kamal H","year":"2020","unstructured":"Kamal H, Westman G, Falconer K, et al.. Long-term study of hepatitis delta virus infection at secondary care centers: the impact of viremia on liver-related outcomes. Hepatology. 2020, 72:1177-1190. 10.1002\/hep.31214","journal-title":"Hepatology"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/v14081749","article-title":"A review of HDV infection","volume":"14","author":"Caviglia GP","year":"2022","unstructured":"Caviglia GP, Ciancio A, Rizzetto M. A review of HDV infection. Viruses. 2022, 14:1749. 10.3390\/v14081749","journal-title":"Viruses"},{"key":"ref38","article-title":"The natural history of chronic delta hepatitis","volume":"234","author":"Bonino F","year":"1987","unstructured":"Bonino F, Negro F, Baldi M, et al.. The natural history of chronic delta hepatitis. Prog Clin Biol Res. 1987, 234:145-152.","journal-title":"Prog Clin Biol Res"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/apt.16485","article-title":"One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease","volume":"54","author":"Palom A","year":"2021","unstructured":"Palom A, Sopena S, Riveiro-Barciela M, et al.. One-quarter of chronic hepatitis D patients reach HDV-RNA decline or undetectability during the natural course of the disease. Aliment Pharmacol Ther. 2021, 54:462-469. 10.1111\/apt.16485","journal-title":"Aliment Pharmacol Ther"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000001424","article-title":"Hepatitis delta and HIV infection","volume":"31","author":"Soriano V","year":"2017","unstructured":"Soriano V, Sherman KE, Barreiro P. Hepatitis delta and HIV infection. AIDS. 2017, 31:875-884. 10.1097\/QAD.0000000000001424","journal-title":"AIDS"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/v14050986","article-title":"Hepatitis B virus-associated hepatocellular carcinoma","volume":"14","author":"Rizzo GE","year":"2022","unstructured":"Rizzo GE, Cabibbo G, Crax\u00ec A. Hepatitis B virus-associated hepatocellular carcinoma. Viruses. 2022, 14:986. 10.3390\/v14050986","journal-title":"Viruses"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v7.i5.777","article-title":"Hepatitis D and hepatocellular carcinoma","volume":"7","author":"Abbas Z","year":"2015","unstructured":"Abbas Z, Abbas M, Abbas S, Shazi L. Hepatitis D and hepatocellular carcinoma. World J Hepatol. 2015, 7:777-786. 10.4254\/wjh.v7.i5.777","journal-title":"World J Hepatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.02.030","article-title":"Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies","volume":"73","author":"Alfaiate D","year":"2020","unstructured":"Alfaiate D, Cl\u00e9ment S, Gomes D, Goossens N, Negro F. Chronic hepatitis D and hepatocellular carcinoma: a systematic review and meta-analysis of observational studies. J Hepatol. 2020, 73:533-539. 10.1016\/j.jhep.2020.02.030","journal-title":"J Hepatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs168","article-title":"A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma","volume":"104","author":"Ji J","year":"2012","unstructured":"Ji J, Sundquist K, Sundquist J. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma. J Natl Cancer Inst. 2012, 104:790-792. 10.1093\/jnci\/djs168","journal-title":"J Natl Cancer Inst"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.4103\/1319-3767.91731","article-title":"Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?","volume":"18","author":"Abbas Z","year":"2012","unstructured":"Abbas Z, Qureshi M, Hamid S, Jafri W. Hepatocellular carcinoma in hepatitis D: does it differ from hepatitis B monoinfection?. Saudi J Gastroenterol. 2012, 18:18-22. 10.4103\/1319-3767.91731","journal-title":"Saudi J Gastroenterol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0092062","article-title":"High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta","volume":"9","author":"Romeo R","year":"2014","unstructured":"Romeo R, Foglieni B, Casazza G, Spreafico M, Colombo M, Prati D. High serum levels of HDV RNA are predictors of cirrhosis and liver cancer in patients with chronic hepatitis delta. PLoS One. 2014, 9:e92062. 10.1371\/journal.pone.0092062","journal-title":"PLoS One"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2019.05.001","article-title":"The oncogenic role of hepatitis delta virus in hepatocellular carcinoma","volume":"1","author":"Puigveh\u00ed M","year":"2019","unstructured":"Puigveh\u00ed M, Moctezuma-Vel\u00e1zquez C, Villanueva A, Llovet JM. The oncogenic role of hepatitis delta virus in hepatocellular carcinoma. JHEP Rep. 2019, 1:120-130. 10.1016\/j.jhepr.2019.05.001","journal-title":"JHEP Rep"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2009.02140.x","article-title":"Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis","volume":"30","author":"Zachou K","year":"2010","unstructured":"Zachou K, Yurdaydin C, Drebber U, et al.. Quantitative HBsAg and HDV-RNA levels in chronic delta hepatitis. Liver Int. 2010, 30:430-437. 10.1111\/j.1478-3231.2009.02140.x","journal-title":"Liver Int"},{"key":"ref49","doi-asserted-by":"crossref","DOI":"10.1177\/135965350701200307","article-title":"Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring","volume":"12","author":"Manesis EK","year":"2007","unstructured":"Manesis EK, Schina M, Le Gal F, et al.. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring. Antivir Ther. 2007, 12:381-388.","journal-title":"Antivir Ther"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.751531","article-title":"Comprehensive analysis of hepatitis delta virus assembly determinants according to genotypes: lessons from a study of 526 hepatitis delta virus clinical strains","volume":"12","author":"Gerber A","year":"2021","unstructured":"Gerber A, Le Gal F, Dziri S, et al.. Comprehensive analysis of hepatitis delta virus assembly determinants according to genotypes: lessons from a study of 526 hepatitis delta virus clinical strains. Front Microbiol. 2021, 12:751531. 10.3389\/fmicb.2021.751531","journal-title":"Front Microbiol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpg.2017.04.010","article-title":"Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants","volume":"31","author":"Lin CL","year":"2017","unstructured":"Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: the role of HBV genotypes and mutants. Best Pract Res Clin Gastroenterol. 2017, 31:249-255. 10.1016\/j.bpg.2017.04.010","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25411","article-title":"Non-F HBV\/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon","volume":"91","author":"Melo Da Silva E","year":"2019","unstructured":"Melo Da Silva E, Kay A, Lobato C, et al.. Non-F HBV\/HDV-3 coinfection is associated with severe liver disease in Western Brazilian Amazon. J Med Virol. 2019, 91:1081-1086. 10.1002\/jmv.25411","journal-title":"J Med Virol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2009.10.036","article-title":"Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D","volume":"52","author":"Schaper M","year":"2010","unstructured":"Schaper M, Rodriguez-Frias F, Jardi R, et al.. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D. J Hepatol. 2010, 52:658-664. 10.1016\/j.jhep.2009.10.036","journal-title":"J Hepatol"},{"key":"ref54","doi-asserted-by":"crossref","DOI":"10.1002\/hep.1840130305","article-title":"Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D","volume":"13","author":"Smedile A","year":"1991","unstructured":"Smedile A, Rosina F, Saracco G, et al.. Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology. 1991, 13:413-416.","journal-title":"Hepatology"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13604","article-title":"Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN)","volume":"38","author":"Wranke A","year":"2018","unstructured":"Wranke A, Pinheiro Borzacov LM, Parana R, et al.. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: the Hepatitis Delta International Network (HDIN). Liver Int. 2018, 38:842-850. 10.1111\/liv.13604","journal-title":"Liver Int"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.4172\/2332-0877.1000271","article-title":"Hepatitis delta virus: epidemiology, natural course and treatment","volume":"4","author":"Sultanik P","year":"2016","unstructured":"Sultanik P, Pol S. Hepatitis delta virus: epidemiology, natural course and treatment. J Infect Dis Ther. 2016, 4:271. 10.4172\/2332-0877.1000271","journal-title":"J Infect Dis Ther"},{"key":"ref57","article-title":"Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children","volume":"364","author":"Crax\u00ec A","year":"1991","unstructured":"Crax\u00ec A, Di Marco V, Volpes R, et al.. Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children. Prog Clin Biol Res. 1991, 364:399-404.","journal-title":"Prog Clin Biol Res"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000000168","article-title":"Clinical presentation of hepatitis D in Pakistani children","volume":"26","author":"Abbas Z","year":"2014","unstructured":"Abbas Z, Soomro GB, Hassan SM, Luck NH. Clinical presentation of hepatitis D in Pakistani children. Eur J Gastroenterol Hepatol. 2014, 26:1098-1103. 10.1097\/MEG.0000000000000168","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.10855","article-title":"The severity of hepatitis D in young adults of age 18-25 years","volume":"12","author":"Abbas Z","year":"2020","unstructured":"Abbas Z, Qadeer MA, Mandviwalla HA, Abbas M. The severity of hepatitis D in young adults of age 18-25 years. Cureus. 2020, 12:e10855. 10.7759\/cureus.10855","journal-title":"Cureus"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu167","article-title":"Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients","volume":"58","author":"Fern\u00e1ndez-Montero JV","year":"2014","unstructured":"Fern\u00e1ndez-Montero JV, Vispo E, Barreiro P, Sierra-Enguita R, de Mendoza C, Labarga P, Soriano V. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Clin Infect Dis. 2014, 58:1549-1553. 10.1093\/cid\/ciu167","journal-title":"Clin Infect Dis"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2004.03.017","article-title":"Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis","volume":"126","author":"Farci P","year":"2004","unstructured":"Farci P, Roskams T, Chessa L, et al.. Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis. Gastroenterology. 2004, 126:1740-1749. 10.1053\/j.gastro.2004.03.017","journal-title":"Gastroenterology"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1111\/liv.15410","article-title":"Interferon-based treatment of chronic hepatitis D [PREPRINT]","author":"Sandmann L","year":"2022","unstructured":"Sandmann L, Wedemeyer H. Interferon-based treatment of chronic hepatitis D [PREPRINT]. Liver Int. 2022, 10.1111\/liv.15410","journal-title":"Liver Int"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27102","article-title":"Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta","volume":"60","author":"Heidrich B","year":"2014","unstructured":"Heidrich B, Yurdayd\u0131n C, Kaba\u00e7am G, et al.. Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta. Hepatology. 2014, 60:87-97. 10.1002\/hep.27102","journal-title":"Hepatology"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13205","article-title":"Non-invasive fibrosis score for hepatitis delta","volume":"37","author":"Lutterkort GL","year":"2017","unstructured":"Lutterkort GL, Wranke A, Yurdaydin C, et al.. Non-invasive fibrosis score for hepatitis delta. Liver Int. 2017, 37:196-204. 10.1111\/liv.13205","journal-title":"Liver Int"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.104691","article-title":"The Delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D","volume":"174","author":"Da BL","year":"2020","unstructured":"Da BL, Surana P, Kleiner DE, Heller T, Koh C. The Delta-4 fibrosis score (D4FS): a novel fibrosis score in chronic hepatitis D. Antiviral Res. 2020, 174:104691. 10.1016\/j.antiviral.2019.104691","journal-title":"Antiviral Res"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.12251","article-title":"Development and evaluation of a baseline-event-anticipation score for hepatitis delta","volume":"21","author":"Calle Serrano B","year":"2014","unstructured":"Calle Serrano B, Gro\u00dfhennig A, Homs M, et al.. Development and evaluation of a baseline-event-anticipation score for hepatitis delta. J Viral Hepat. 2014, 21:154-163. 10.1111\/jvh.12251","journal-title":"J Viral Hepat"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i22.967","article-title":"Serum cholinesterase: a predictive biomarker of hepatic reserves in chronic hepatitis D","volume":"9","author":"Abbas M","year":"2017","unstructured":"Abbas M, Abbas Z. Serum cholinesterase: a predictive biomarker of hepatic reserves in chronic hepatitis D. World J Hepatol. 2017, 9:967-972. 10.4254\/wjh.v9.i22.967","journal-title":"World J Hepatol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault NA","year":"2018","unstructured":"Terrault NA, Lok AS, McMahon BJ, et al.. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018, 67:1560-1599. 10.1002\/hep.29800","journal-title":"Hepatology"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin SK","year":"2016","unstructured":"Sarin SK, Kumar M, Lau GK, et al.. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016, 10:1-98. 10.1007\/s12072-015-9675-4","journal-title":"Hepatol Int"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"European Association for the Study of the Liver","year":"2017","unstructured":"European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. 2017, 67:370-398. 10.1016\/j.jhep.2017.03.021","journal-title":"J Hepatol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06584-w","article-title":"Enhanced screening for hepatitis D in the USA: overcoming the\u00a0delta\u00a0blues","volume":"66","author":"Terrault NA","year":"2021","unstructured":"Terrault NA, Ghany MG. Enhanced screening for hepatitis D in the USA: overcoming the\u00a0delta\u00a0blues. Dig Dis Sci. 2021, 66:2483-2485. 10.1007\/s10620-020-06584-w","journal-title":"Dig Dis Sci"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100547","article-title":"Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D","volume":"4","author":"Palom A","year":"2022","unstructured":"Palom A, Rando-Segura A, Vico J, et al.. Implementation of anti-HDV reflex testing among HBsAg-positive individuals increases testing for hepatitis D. JHEP Rep. 2022, 4:100547. 10.1016\/j.jhepr.2022.100547","journal-title":"JHEP Rep"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10285-5","article-title":"Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy","volume":"16","author":"Kumar M","year":"2022","unstructured":"Kumar M, Abbas Z, Azami M, et al.. Asian Pacific association for the study of liver (APASL) guidelines: hepatitis B virus in pregnancy. Hepatol Int. 2022, 16:211-253. 10.1007\/s12072-021-10285-5","journal-title":"Hepatol Int"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/173697-an-insight-into-the-factors-affecting-the-prevalence-and-natural-history-of-hepatitis-d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:31Z","timestamp":1707508891000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/173697-an-insight-into-the-factors-affecting-the-prevalence-and-natural-history-of-hepatitis-d"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":73,"URL":"https:\/\/doi.org\/10.7759\/cureus.43362","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8,12]]}}}